Meredith Manning, Chief Commercial Officer: Soleno Therapeutics SLNO Sell · Filed 25/03/31

Trade details

Type: Insider sale
Amount: $178,785.21
Shares · price: 2,599 sh · $68.79 a share
Held after: 47,270 sh
Stock: Soleno Therapeutics SLNO
Person: Meredith ManningChief Commercial Officer
Trade date: 25/03/27
Filed: 25/03/31
Days to filing: 4 days

Sold 5.2% of holdings

Share of holding sold: 5.2%

Soleno Therapeutics trades, last 26 weeks

What else happened in Soleno Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/25~25/04/26

Meredith Manning's recent trades

Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$146.1K
4,864 sh
$146.1K
Filed 03/31
Traded 03/27
Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$65.2K
2,100 sh
$65.2K
Filed 03/31
Traded 03/27
Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$17.7K
558 sh
$17.7K
Filed 03/31
Traded 03/27
Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$2.5M
37,000 sh
$2.5M
Filed 25/03/31
Traded 25/03/27
Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$133.8K
1,976 sh
$133.8K
Filed 25/03/31
Traded 25/03/27

Meredith Manning, Chief Officer — sold $178.8K of Soleno Therapeutics SLNO · 5.2% of holdings | Whalegun